Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Legislators Finalize BBA Relief Measure; White House Threatens Veto

This article was originally published in The Gray Sheet

Executive Summary

Two provisions of Reps. Jim Ramstad (R-Minn) and Karen Thurman's (D-Fla.) Medicare Patient Access to Technology Act (HR 4395) apparently did not survive eleventh-hour maneuvering between the White House and House Republicans in negotiating this year's Balanced Budget Act relief package.
Advertisement

Related Content

BBA Relief Break From Tax Package Augured By Bipartisan Support
BBA Relief Break From Tax Package Augured By Bipartisan Support
Medicare Giveback Package Includes $1.5 Bil. For Screening Initiatives
Medicare Giveback Package Includes $1.5 Bil. For Screening Initiatives
Medicare OPPS Pass-Through Payment 50% Cut Likely On Jan. 1
Medicare OPPS Pass-Through Payment 50% Cut Likely On Jan. 1
BBA Relief Act Seeks By-Category Device Grouping Under Outpatient PPS
Further BBA Relief Legislation To Be Marked Up By Mid-September
Further BBA Relief Legislation To Be Marked Up By Mid-September
Advertisement
UsernamePublicRestriction

Register

MT014011

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel